サインイン

Marco Giallombardo

Department of Biopathology and Medical Biotechnology,
Section of Biology and Genetics,
Department of Biopathology and Medical Biotechnology, Section of Biology and Genetics

University of Palermo

BIOGRAPHY

Marco Giallombardo has not added Biography.

If you are Marco Giallombardo and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells.

Molecular cancer , 2014 | Pubmed ID: 25015105

Nintedanib in non-small cell lung cancer: from preclinical to approval.

Therapeutic advances in respiratory disease Aug, 2015 | Pubmed ID: 25855060

Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21.

Oncotarget Sep, 2015 | Pubmed ID: 26116834

Reduction in mdx mouse muscle degeneration by low-intensity endurance exercise: a proteomic analysis in quadriceps muscle of exercised compared with sedentary mdx mice.

Bioscience reports , 2015 | Pubmed ID: 26182375

Entrectinib: a potent new TRK, ROS1, and ALK inhibitor.

Expert opinion on investigational drugs , 2015 | Pubmed ID: 26457764

In silico pathway analysis in cervical carcinoma reveals potential new targets for treatment.

Oncotarget Jan, 2016 | Pubmed ID: 26701206

The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer.

Expert opinion on investigational drugs Apr, 2016 | Pubmed ID: 26881293

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice.

Oncotarget Feb, 2016 | Pubmed ID: 26919248

BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?

Critical reviews in oncology/hematology May, 2016 | Pubmed ID: 26960735

Curcumin modulates chronic myelogenous leukemia exosomes composition and affects angiogenic phenotype, via exosomal miR-21.

Oncotarget Mar, 2016 | Pubmed ID: 27050372

INSTITUTIONS

University of Palermo

Antwerp University Hospital (UZA)

JOVE ARTICLES

Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Marco Giallombardo^*,1,2,

Jorge Chacártegui Borrás^*,2,3,

Marta Castiglia⁴,

Nele Van Der Steen³,

Inge Mertens^5,6,

Patrick Pauwels^7,3,

Marc Peeters^8,3,

Christian Rolfo^2,3

¹Department of Biopathology and Medical Biotechnology, Section of Biology and Genetics, University of Palermo,

²Phase I-Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital (UZA),

³Center for Oncological Research (CORE), Antwerp University,

⁴Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo,

⁵, Flemish Institute for Technological Research (VITO),

⁶CORE, Campus Groenenborger, Antwerp University,

⁷Molecular Pathology, Pathology Department, Antwerp University Hospital (UZA),

⁸Oncology Department, Antwerp University Hospital (UZA)

Medicine

個人情報保護方針

利用規約

一般データ保護規則

お問い合わせ

図書館への推薦

JoVE ニュースレター

研究

JoVE Journal
メソッドコレクション
JoVE Encyclopedia of Experiments
アーカイブ

教育

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教員向けリソースセンター
教員用サイト

著者

概要
出版プロセス
編集委員会
スコープと指針
査読
よくある質問
お申し込み

図書館員

概要
お客様の声
定期購読
アクセス
リソース
図書館諮問委員会
よくある質問

JoVEについて

概要
経営陣
ブログ
JoVE Help Center

Marco Giallombardo

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Biopathology and Medical Biotechnology,Section of Biology and Genetics,Department of Biopathology and Medical Biotechnology, Section of Biology and Genetics

University of Palermo

Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Department of Biopathology and Medical Biotechnology,
Section of Biology and Genetics,
Department of Biopathology and Medical Biotechnology, Section of Biology and Genetics